Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Review
Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 1,637 | Dovepress* | 1,379+ | 49 | 1,428 | |
| PubMed Central* | 258 | 127 | 385 | ||
| Totals | 1,637 | 176 | 1,813 | ||
| *Since 24 October 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar